About Pathway Genomics
Pathway Genomics Industries Press Mentions
Stay in the know about the latest news on Pathway Genomics Industries
Investors in Pathway Genomics Industries
Discover investors in Pathway Genomics Industries stock and explore their portfolio companies
Pathway Genomics Industries Management
Leadership team at Pathway Genomics Industries
Management Team
Kamal Adawi
CFO
K'Lene Oen
Chief Business Officer
Nilesh Dharajiya MD
Chief Laboratory Officer & Medical Director
James Plante
Founder, Board Member, CEO
Glenn Braunstein MD
Chief Medical Officer
Anja Kammesheidt Ph.D
Chief Scientific Officer
Michael Nova Ph.D
Chief Innovation Officer
Board Members
Christopher Kitching
Mark Sopp
Pathway Genomics
Peter Leddy Ph.D
Peter Pace
Register To Buy and Sell Shares
For more details on private stock price information, financing and valuation for Pathway Genomics, register or login.
- Pathway Genomics's current valuation
- Pathway Genomics's stock price
- Explore available deals for Pathway Genomics and other companies
- Access deal offering documents
- Pre-Ipomarket's exclusive data and insights, including:
- Cap tables showing funding history by Share Class and Liquidity Preferences
- Key Company Highlights
- Detailed Business Model
- Identified Risk Factors
By registering, you agree to StockMe's Terms of Use. Already registered? Log in
Frequently Asked Questions
How to invest in Pathway Genomics shares?
Accredited investors can purchase pre-IPO stock in companies like Pathway Genomics through platforms like pre-ipomarket. These shares are typically offered by early employees who are seeking liquidity for personal life events, such as buying a home or funding education. Investors can access these opportunities through funds similar to those used by hedge funds for large investors. While private company investments come with risks, they offer the potential for portfolio diversification, access to growth, and high returns. Learn more about our guided investment process.
How to sell Pathway Genomics shares?
Shareholders have the option to sell their Pathway Genomics stock through pre-ipomarket’s private company marketplace. The platform connects sellers with a large network of accredited investors who are interested in purchasing shares of private companies. Learn more about the streamlined and guided process for shareholders here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on pre-ipomarket. The first is if the company undergoes an exit event, such as an IPO, merger, or acquisition. In such cases, your shares and/or cash will be distributed directly to you. The second option, if eligible, is through an Express Deal. This allows you to sell your allocation of private shares in a specific company to another investor via the pre-ipomarket platform.
Why choose Pre-Ipomarket?
pre-ipomarket has simplified the process of buying and selling shares in private companies. The platform connects investors with shareholders, offering liquidity to early shareholders and providing accredited investors with access to private market opportunities. With low investment minimums and over 42K private placements completed across 450+ companies, pre-ipomarket is a leader in making "Private Markets for the Public."
